Primary Intestinal Lymphangiectasia

WikiDoc Resources for Primary Intestinal Lymphangiectasia
Articles
Most recent articles on Primary Intestinal Lymphangiectasia Most cited articles on Primary Intestinal Lymphangiectasia Review articles on Primary Intestinal Lymphangiectasia Articles on Primary Intestinal Lymphangiectasia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Primary Intestinal Lymphangiectasia Images of Primary Intestinal Lymphangiectasia Photos of Primary Intestinal Lymphangiectasia Podcasts & MP3s on Primary Intestinal Lymphangiectasia Videos on Primary Intestinal Lymphangiectasia
Evidence Based Medicine
Cochrane Collaboration on Primary Intestinal Lymphangiectasia Bandolier on Primary Intestinal Lymphangiectasia TRIP on Primary Intestinal Lymphangiectasia
Clinical Trials
Ongoing Trials on Primary Intestinal Lymphangiectasia at Clinical Trials.gov Trial results on Primary Intestinal Lymphangiectasia Clinical Trials on Primary Intestinal Lymphangiectasia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Primary Intestinal Lymphangiectasia NICE Guidance on Primary Intestinal Lymphangiectasia NHS PRODIGY Guidance FDA on Primary Intestinal Lymphangiectasia CDC on Primary Intestinal Lymphangiectasia
Books
Books on Primary Intestinal Lymphangiectasia
News
Primary Intestinal Lymphangiectasia in the news Be alerted to news on Primary Intestinal Lymphangiectasia News trends on Primary Intestinal Lymphangiectasia
Commentary
Blogs on Primary Intestinal Lymphangiectasia
Definitions
Definitions of Primary Intestinal Lymphangiectasia
Patient Resources / Community
Patient resources on Primary Intestinal Lymphangiectasia Discussion groups on Primary Intestinal Lymphangiectasia Patient Handouts on Primary Intestinal Lymphangiectasia Directions to Hospitals Treating Primary Intestinal Lymphangiectasia Risk calculators and risk factors for Primary Intestinal Lymphangiectasia
Healthcare Provider Resources
Symptoms of Primary Intestinal Lymphangiectasia Causes & Risk Factors for Primary Intestinal Lymphangiectasia Diagnostic studies for Primary Intestinal Lymphangiectasia Treatment of Primary Intestinal Lymphangiectasia
Continuing Medical Education (CME)
CME Programs on Primary Intestinal Lymphangiectasia
International
Primary Intestinal Lymphangiectasia en Espanol Primary Intestinal Lymphangiectasia en Francais
Business
Primary Intestinal Lymphangiectasia in the Marketplace Patents on Primary Intestinal Lymphangiectasia
Experimental / Informatics
List of terms related to Primary Intestinal Lymphangiectasia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Synonyms and keywords:

Historical Perspective

• Primary intestinal lymphangiectasia (Waldmann's disease) was first discovered by Waldmann T.A. in 1961 when he reported 18 cases of patients having edema with low serum albumin and gammaglobulin and proteins levels ''idiopathic hypercatabolic hypoproteinemia".
• Assessment using radio-labeled ¹³¹I-albumin resulted in low levels in those patients. In addition, small intestinal biopsies were examined under a microscope revealing different degrees of lymphatic vessel dilatation.

Classification

• [Disease name] may be classified according to [classification method] into [number] subtypes/groups:

• [group1]
• [group2]
• [group3]

• Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

Pathology

PIL develops as a result of dilatation of intestinal lymphatic vessels (lacteals) with leakage of their contents into the bowel lumen leading to hypoalbuminemia, hypogammaglobulinemia, and lymphopenia. Hypoproteinemia leads to edema. It is a form of protein-losing enteropathy.

Genetics

Genes involved in the pathogenesis of PIL include VEGFR3, LYVE-1, PROX1, and FOXC2 that are abnormally expressed in patients with PIL.

Associated conditions

• There are five syndromes that have been reported to be associated with PIL. These syndromes include:
  • Turner syndrome
  • Noonan syndrome
  • von Recklinghausen disease
  • Klippel-Trenaunay syndrome
  • Hennekam syndrome

Gross pathology

The jejunal villi appear creamy yellowish or whitish due to the dilated lymphatics in the intestinal mucosa.

Microscopic Pathology

The most important histopathological characteristics of PIL are dilated intestinal lymphatic vessels and lacteal juice in the biopsies from duodenum, jejunum and ileum.

Causes

Disease name] may be caused by [cause1], [cause2], or [cause3].

OR

Common causes of [disease] include [cause1], [cause2], and [cause3].

OR

The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].

OR

The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.

Differentiating [disease name] from other Diseases

PIL must be differentiated from the secondary causes that lead to intestinal lymphangiectasia such as:

• Intestinal tuberculosis
• Inflammatory bowel disease, *Intestinal lymphoma,
• Constrictive pericarditis
• Sarcoidosis
• Systemic sclerosis
• Whipple disease
• Radiation and/or chemotherapy with retroperitoneal fibrosis
• HIV-related enteropathy
• Fatigue
• Abdominal pain
• Abdominal mass
• Immunodeficiency
• Vitamin D deficiency Leading to osteomalacia and convulsion
• Iron deficiency anemia
• Mechanical ileus
• Chylous reflux into skin
• Recurrent GI bleeding
• Children have growth retardation

Physical Examination

• Patients with [disease name] usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with [disease name].

• A [positive/negative] [test name] is diagnostic of [disease name].
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
• Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Electrocardiogram

There are no ECG findings associated with [disease name].

OR

An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

X-ray

There are no x-ray findings associated with [disease name].

OR

An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Echocardiography or Ultrasound

There are no echocardiography/ultrasound findings associated with [disease name].

OR

Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

CT scan

There are no CT scan findings associated with [disease name].

OR

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

MRI

There are no MRI findings associated with [disease name].

OR

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Other Imaging Findings

There are no other imaging findings associated with [disease name].

OR

[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

There are no other diagnostic studies associated with [disease name].

OR

[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for [disease name]; the mainstay of therapy is supportive care.

• The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action 1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for [disease name].
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
• [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

• There are no primary preventive measures available for [disease name].

• Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].